- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 10.49M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 10.37M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.78M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $543K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $19.63M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $31.28M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $71.81M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $69.97M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $53.72M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $52.37M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.57M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $9.68M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $9.88M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $15M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $43.59M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $53.27M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $81.69M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $84.96M |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.16M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $535K |
| Net Income | Q1 2026 · Mar 31, 2026 | $1.99M |
| Net Income | Q1 2026 · Mar 31, 2025 | $1.59M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $1.54M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $1.74M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $14.67M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $10.29M |
| Revenue | Q1 2026 · Mar 31, 2026 | $17.45M |
| Revenue | Q1 2026 · Mar 31, 2025 | $12.64M |